Moshe Mizrahi

Steel Partners issues an 11-day ultimatum to InMode over its $16.75 per share buyout offer, citing stalled negotiations, lack of data room access, and escalating legal disputes between the activist fund and the medical aesthetics company's board.

An American fund has filed a lawsuit against the chairman of InMode, alleging he is the de facto controlling shareholder despite owning only 7% of the company. The plaintiff seeks stricter oversight of the acquisition process.